TECTONIC THERAPEUTIC, INC. Payments for Repurchase of Initial Public Offering
TECTONIC THERAPEUTIC, INC. (TECX) reported Payments for Repurchase of Initial Public Offering of $55.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2019-05-13
- TECTONIC THERAPEUTIC, INC. payments for repurchase of initial public offering for the quarter ending 2018-03-31 was $55.00K.
| Period end | Payments for Repurchase of Initial Public Offering 3 month |
|---|---|
| 2018-03-31 | $55.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |